PathoGenetix Raises $4M in First Close of Series B
August 01, 2011
PathoGenetix Raises $4M in First Close of Series B
The company, once called US Genomics, will use the funds to complete development of its first commercial systems for identifying pathogens in complex biological samples.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.